Skip to main content
GNOM logo
GNOM
(NASDAQ)
Global X Genomics & Biotechnology ETF
$58.17-- (--)
Loading... - Market loading

GNOM ETF: Global X Genomics & Biotechnology ETF - Price, Holdings & Analysis

Global X Genomics & Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$55.03 - $55.87
52-Week High$59.48
52-Week Low$34.04
Open$55.60
Volume15.51K
Average Volume (3M)37.75K
Assets (AUM)78.81M
Expense Ratio0.50%
Total Holdings51
Inception DateApr 5, 2019
1 Day Change1.68%
1 Month Change-5.12%
6 Month Change20.99%
YTD Change22.22%
1 Year Change60.11%
52-Week Change57.95%
5 Year Change-42.08%
50-Day MA$53.03
200-Day MA$47.49
RSI56.66
Stochastic %K93.77
Stochastic %D60.84
Annual Dividend$0.68
Dividend Yield1.22%
Last Dividend Ex-DateJul 7, 2026
Dividend Growth YoY1959.84%

Frequently Asked Questions About Global X Genomics & Biotechnology ETF

What is the current price of GNOM?

The latest GNOM price is $55.81. The 52-week range is $34.04–$59.48. GNOM has returned 57.9% over the past 52 weeks.

What is the expense ratio for GNOM?

GNOM's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does GNOM pay dividends?

Yes, GNOM pays a 1.22% dividend yield. The last ex-dividend date was 2026-07-07. View full dividend history in the Dividends section.

What are the top holdings of GNOM?

GNOM's largest holdings are Guardant Health, Inc (5.8%), Legend Biotech Corporation (5.4%), Illumina, Inc. (5.3%) (combined weight: 16.6%). The fund holds 51 total positions. View the complete portfolio breakdown in the Holdings section.

How does GNOM compare to similar ETFs?

Compare GNOM (0.50% expense ratio, $79M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.